“borderline significant”

The main effect of Type of HoloLens was not significant for both tasks (2D stepping target: F (1,15) = 0.76, p = 0.398, ƞ p 2 = 0.048; 3D obstacle crossing: F (1,15) = 2.64, p = 0.125, ƞ p 2 = 0.149), while the Type of Object × Type of HoloLens interaction was borderline significant for 2D target-stepping ( F (1,15) = 4.34, p = 0.055, ƞ p 2 = 0.225; Fig 5B ) and 3D obstacle-crossing ( F (1,15) = 4.62, p = 0.048, ƞ p 2 = 0.235; Fig 4C ) tasks, indicating that, at least for holographic 3D obstacle crossing, the initial orientation was significantly smaller for HoloLens 2 than for HoloLens 1 ( t (15) = 2.23, p = 0.041) in the absence of HoloLens differences for real-world 3D obstacles ( t (15) = -0.57, p = 0.578), a finding consistent with our expectations regarding the difference in AR-FOV size between HoloLenses.

Primary bile acid deconjugation potential was lower in IBD patients but only borderline significant after adjustment for FDR (adjusted p value = 0.0551); however, the abundance of the bile salt hydrolase reaction was significantly reduced in IBD microbiomes ( p value 0.0235, Additional file 1 : Table S7) and also differed based on phylum-and genus-level reaction abundances for many taxa (Additional file 1 : Table S7).

Although a chi-square test initially suggested a borderline significant variation across tumor types ( p = 0.0551), this association lost statistical significance after adjusting for multiple comparisons (adjusted p = 0.2057).

For GI bleeds (n=210), two models showed no difference but one model was borderline significant (p<.0552). 4.

In contrast, those with a diagnosis of stage IV disease had a borderline significant association based on their ctDNA KRAS level ( p = 0.0554; Figure 5B ).

For miR-660-5p, a significant (p-value < 0.05) and a borderline significant (p = 0.0554) enrichment of predicted target genes was observed (Fig. 5C ).

When we analyzed the AMD subgroups separately ( Appendix 3 ), we found a borderline significant effect in the Rotterdam Study for the CNV cases (p=0.0554).

Rehabilitation showed a borderline significant effect on 3-month survival ( p = 0.0554), but not on the weaning rate or RCC survival.

Administration of anti-Ly6G antibody significantly suppressed CCRK-induced PMN-MDSC accumulation in liver ( p < 0.01), leading to a borderline significant reduction in HCC tumorigenicity ( p = 0.0555; Supplementary Fig. 5e, f ).

Age was borderline significant at a 5% level ( p = 0.0556).

A borderline significant interaction was observed for EASI‐90 response rate (37.1% vs. 18.8%, interaction p = 0.0556), indicating a trend toward more pronounced improvement in the comorbid subgroup.

For sulforaphane, the respective decrease was borderline significant (−14.4 ± 21.7%, p = 0.0556).

Results suggested that patients in the NADM8 high group tend to be more sensitive to the treatment of PI3K inhibitor GDC-0941 as compared with the NADM8 low group, although it is borderline significant (P = 0.0556) due to the limited sample size ( Figure 6K ).

There was also a borderline significant correlation between H19 and G6pc ( P =0.0556; Figure 2h ).

Statistical analysis indicated a borderline significant relationship between tumor morphology and therapy response (Fisher's exact test: p = 5.58 × 10 −2 , n = 67).

Among rural dwellers, the non-linearity χ 2 was borderline significant (p=0.0558) thereby indicating possible departure from linearity.

Results We found a borderline significant association of occurrence of AMI with the ACE D/I polymorphism (DD genotype, 42% in cases vs 31% in controls; p = 0.056).

Although only FEV 1 (% predicted) revealed significant difference between PP and TP, FVC (% predicted) showed borderline significant differences ( p = 0.056).

Tumor size was borderline significant ( p = 0.056), and patients with early stage tumors tended to have a longer time to progression.

The interaction between CMVR and recipient age on OS was borderline significant ( P = .056).

High S100A monocyte gene expression was associated with elevated plasma levels of protein S100A8, while the elevation of protein S100A9 was borderline significant ( p = 0.056) ( Figure 6 ).

The association between TL and kidney function remained robust even after adjusting for potential confounding factors, but the association between TL and ACR was only borderline significant (β-coefficient= -0.012, p =0.056).

This variable entered the broad model as borderline significant ( p = 0.056, 95%-CI = 0.05–1.04), but did not meet the inclusion criteria for the narrow model.

When exploring the association between new-onset conduction disturbances and all-cause mortality in the stratified Cox proportional hazards regression analysis, the association between new-onset LBBB and all-cause mortality was borderline significant in the unadjusted model (HR, 1.65 [95% CI, 0.99–2.76]; P =0.056).

Concerning the second study question, a borderline significant association was apparent between effect size and age ( P = .056), but no associations of effect size with percentage of female patients, standard errors, or any variable describing differences in treatment regimens.